Mr Matthew Fisher
BSc (Hons)
School of Medicine and Population Health
Technical Specialist – BSU
matthew.fisher@sheffield.ac.uk
+44 114 215 9067
+44 114 215 9067
GU36, The Medical School
Full contact details
Mr Matthew Fisher
School of Medicine and Population Health
GU36
The Medical School
Beech Hill Road
Sheffield
S10 2RX
School of Medicine and Population Health
GU36
The Medical School
Beech Hill Road
Sheffield
S10 2RX
- Research interests
-
The TMG study the blood vessels that supply tumours with oxygen and nutrients and their role in cancer therapy. Tumours require a blood supply to grow and the blood vessels provide a route for the spread of tumour cells to other sites in the body. Therefore, targeting treatment to the blood vessels rather than the tumour cells is a potential means of killing tumours. Much of the research involves using vascular disrupting agents (VDAs) e.g. CA4P, and the susceptibility of tumour vessels to vascular shutdown.
- Publications
-
Show: Featured publications All publications
Featured publications
This person does not have any publications available.
All publications
Journal articles
- . Journal for ImmunoTherapy of Cancer, 12(7).
- . eBioMedicine, 104.
- . PLoS Biology, 21(1).
- . ChemMedChem, 13(24), 2600-2600.
- . ChemMedChem, 13(24), 2618-2626.
- . PLoS One, 13(6).
- . Biomedical Optics Express, 8(10), 4551-4567.
- . Oncotarget, 2017(8), 95648-95661.
- . Cancer Research, 77(10), 2633-2646.
- . Journal of Medicinal Chemistry, 59(20), 9473-9488.
- . British Journal of Pharmacology, 171(21), 4902-4913.
- . International Journal of Cancer, n/a-n/a.
- . PLoS ONE, 7(5).
- . Cancer Research, 72(8_Supplement), 5296-5296.
- . Cancer Research, 72(8_Supplement), 1371-1371.
- . Cancer Research, 71(8_Supplement), 3279-3279.
- . Cancer Research, 71(8_Supplement), 2849-2849.
- . International Journal of Cancer, 129(8), 1979-1989.
- . Journal of Clinical Investigation, 121(5), 1969-1973.
- . Medical Engineering and Physics, 33(7), 805-809.
- Microflow of fluorescently labelled red blood cells in tumours expressing single isoforms of VEGF and their response to vascular targeting agents. Medical Engineering and Physics.
Conference proceedings
- Genetically Determined Peptidylglycine Alpha-amidating Monooxygenase (PAM) Mediated Amidation Regulates Tissue Damage by Rheumatoid Arthritis Synovial Fibroblasts. ARTHRITIS & RHEUMATOLOGY, Vol. 76 (pp 1864-1865)
- Using glycan targeting drugs to block prostate cancer bone metastasis. GLYCOBIOLOGY, Vol. 33(11) (pp 1043-1043)
- VEGFA isoform switching in soft tissue sarcoma is associated with decreased survival. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 100(4) (pp A41-A41)
- Differences in VEGFA isoform expression regulate modes of migration and their sensitivity to anti-VEGFA therapy. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 100(4) (pp A25-A25)
- . Cancer Research, Vol. 75(1_Supplement) (pp A57-A57)
- . Cancer Research, Vol. 71(8_Supplement) (pp 1578-1578)
Preprints
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.